Stay updated on Belantamab vs Bortezomib in MM Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a unified Locations section with listed sites across Arizona, Florida, Massachusetts, Missouri, Tennessee, Australian Capital Territory, New South Wales, Queensland, South Australia, Victoria, and Western Australia, and updated the revision to v3.3.3; the previous separate location subpages (Arizona Locations, Florida Locations, etc.) were removed.
    Difference
    0.6%
    Check dated 2025-12-23T09:19:05.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added related topics (Multiple myeloma and MedlinePlus Genetics) and updated the Publications section with a 2025 Blood Advances article, while removing the earlier Blood Advances citation.
    Difference
    0.1%
    Check dated 2025-12-09T00:33:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer revision label updated from v3.3.1 to v3.3.2, with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:54:04.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page adds a note that publications are automatically filled from PubMed and updates the revision tag to v3.3.1. No substantive study information is changed.
    Difference
    0.1%
    Check dated 2025-11-24T14:53:23.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added a citation for the DREAMM-8 publication in Lancet Haematol 2025 detailing patient-reported outcomes. Removed a generic government funding notice that does not affect the study content.
    Difference
    0.2%
    Check dated 2025-11-17T07:17:59.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Changes appear limited to UI/layout tweaks and do not affect core study content such as arms, endpoints, enrollment, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:23:41.000Z thumbnail image

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.